See also: Generic Ditropan XL
Ditropan is a brand name of oxybutynin, approved by the FDA in the following formulation(s):
DITROPAN (oxybutynin chloride - tablet; oral)
Manufacturer: JANSSEN PHARMS
Approved Prior to Jan 1, 1982
Strength(s): 5MG [RLD][AB]
Has a generic version of Ditropan been approved?
Yes. The following products are equivalent to Ditropan:
oxybutynin chloride tablet; oral
Manufacturer: PLIVA
Approval date: November 14, 1988
Strength(s): 5MG [AB]
Manufacturer: USL PHARMA
Approval date: July 31, 1996
Strength(s): 5MG [AB]
Manufacturer: VINTAGE PHARMS
Approval date: October 31, 1997
Strength(s): 5MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ditropan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Ditropan.
See also...
- Ditropan Consumer Information (Drugs.com)
- Ditropan Consumer Information (Wolters Kluwer)
- Ditropan Syrup Consumer Information (Wolters Kluwer)
- Ditropan Consumer Information (Cerner Multum)
- Ditropan Advanced Consumer Information (Micromedex)
- Oxybutynin Consumer Information (Drugs.com)
- Oxybutynin Consumer Information (Wolters Kluwer)
- Oxybutynin Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Oxybutynin Gel Consumer Information (Wolters Kluwer)
- Oxybutynin Syrup Consumer Information (Wolters Kluwer)
- Oxybutynin System Consumer Information (Wolters Kluwer)
- Oxybutynin Consumer Information (Cerner Multum)
- Oxybutynin topical Consumer Information (Cerner Multum)
- Oxybutynin transdermal Consumer Information (Cerner Multum)
- Oxybutynin Advanced Consumer Information (Micromedex)
- Oxybutynin Transdermal Advanced Consumer Information (Micromedex)
- Oxybutynin Chloride AHFS DI Monographs (ASHP)
No comments:
Post a Comment